Evidence map›Paper›PMID 41068219›Full record

ArticleScientific reports2025

A robust deep learning classifier for screening multiple retinal diseases on optical coherence tomography.

Philippe Zhang, Gwenole Quellec, Sarah Matta, Laurent Borderie, Alexandre Le Guilcher, Tanguy Thiery, Béatrice Cochener, Mathieu Lamard

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Philippe ZhangLaTIM UMR 1101, Inserm, Brest, France. pzhang.wj88@gmail.com.
Gwenole QuellecLaTIM UMR 1101, Inserm, Brest, France.
Sarah MattaLaTIM UMR 1101, Inserm, Brest, France.
Laurent BorderieEvolucare Technologies, Villers-Bretonneux, France.
Alexandre Le GuilcherEvolucare Technologies, Villers-Bretonneux, France.
Tanguy ThieryOphthalmology Department, CHRU Brest, Brest, France.
Béatrice CochenerLaTIM UMR 1101, Inserm, Brest, France.
Mathieu LamardLaTIM UMR 1101, Inserm, Brest, France.

Funding

Agence Nationale de la Recherche ANR-19-LCV2-0005 - ADMIRE project
6 · The paper itself

Abstract

Retinal diseases are among the leading causes of visual impairment worldwide, where timely diagnosis and management are critical to prevent irreversible vision loss and blindness, especially in regions with limited access to ophthalmologists. While artificial intelligence (AI) has shown remarkable potential for screening ocular diseases, many existing models are heavily dependent on the datasets used for their development and often experience significant performance drops when tested on external datasets. These limitations in robustness and generalizability reduce their practical applicability in clinical settings. In this study, we proposed our newly developed deep learning architecture, FlexiVarViT is designed to enhance robustness and generalizability by addressing the unique characteristics of optical coherence tomography (OCT) imaging, such as variable data (e.g., number of slices, resolution), while processing B-scans at their native resolution (i.e., without resizing) to preserve fine anatomical details. Our method was evaluated on three datasets for the accurate detection and classification of multiple retinal pathologies using OCT images. These datasets represent diverse imaging devices (Spectralis and Optovue) and populations from France, Russia, and Iran. The results highlight the versatility, robustness, and generalizability of our model across various patient demographics and imaging systems, demonstrating significant improvements compared to state-of-the-art methods and emphasizing its potential for clinical application.

Indexed as

Deep LearningRetinal DiseasesTomography, Optical CoherenceHumansRetina

Identifiers

PMID41068219
PMCPMC12511338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.